Holen Sie sich die Stockscreener-App
11.33
1.43%
0.17
Schlusskurs vom Vortag:
$11.16
Offen:
$11.15
24-Stunden-Volumen:
601.01K
Relative Volume:
0.70
Marktkapitalisierung:
$1.18B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-238.77M
KGV:
-0.4226
EPS:
-26.808
Netto-Cashflow:
$-216.62M
1W Leistung:
+52.76%
1M Leistung:
+139.82%
6M Leistung:
+230.02%
1J Leistung:
+31.47%
1-Tages-Spanne:
$10.75
$11.45
1-Wochen-Bereich:
$7.41
$11.45
52-Wochen-Spanne:
$2.7601
$11.45
Alumis Inc Stock (ALMS) Company Profile
Firmenname
Alumis Inc
Sektor
Branche
Telefon
650-231-6625
Adresse
280 EAST GRAND AVENUE, SOUTH SAN FRANCISCO
Vergleichen Sie ALMS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ALMS
Alumis Inc
|
11.31 | 1.17B | 0 | -238.77M | -216.62M | -26.81 |
|
VRTX
Vertex Pharmaceuticals Inc
|
440.32 | 112.15B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
698.26 | 73.91B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
417.61 | 56.81B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
893.75 | 55.46B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
194.55 | 41.92B | 447.02M | -1.18B | -906.14M | -6.1812 |
Alumis Inc Stock (ALMS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-25 | Eingeleitet | Wells Fargo | Overweight |
| 2025-06-10 | Fortgesetzt | Guggenheim | Buy |
| 2025-01-30 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-31 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-10-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-07-23 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-07-23 | Eingeleitet | Guggenheim | Buy |
| 2024-07-23 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-23 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Alumis Inc Aktie (ALMS) Neueste Nachrichten
Alumis stock hits 52-week high at 11.3 USD By Investing.com - Investing.com Canada
Assessing Alumis (ALMS) Valuation After Director Srinivas Akkaraju’s $2 Million Insider Share Purchase - simplywall.st
Can Alumis Stock Hold Up When Markets Turn? - Trefis
What Do Director Insider Buys Reveal About Alumis’ (ALMS) Long-Term Alignment With Shareholders? - simplywall.st
Alumis (NASDAQ:ALMS) Trading Up 11.8% Following Insider Buying Activity - MarketBeat
Aug PreEarnings: Can Alumis Inc stock continue upward trendJuly 2025 Price Swings & AI Powered Market Entry Strategies - BỘ NỘI VỤ
Alumis (NASDAQ:ALMS) Hits New 12-Month High on Analyst Upgrade - MarketBeat
Alumis (NASDAQ:ALMS) Rating Increased to Hold at Wall Street Zen - MarketBeat
Alumis (NASDAQ:ALMS) Raised to Hold at Wall Street Zen - MarketBeat
Alumis (NASDAQ:ALMS) Director Purchases $540,100.86 in Stock - MarketBeat
Insider Buying: Alumis (NASDAQ:ALMS) Director Acquires 100,000 Shares of Stock - MarketBeat
Insider Stock Purchases: December 05, 2025 - Quiver Quantitative
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
349,615 Shares in Alumis Inc. $ALMS Bought by Stonepine Capital Management LLC - MarketBeat
After losing 3.7% in the past year, Alumis Inc. (NASDAQ:ALMS) institutional owners must be relieved by the recent gain - simplywall.st
Can Alumis Inc. stock continue upward trend2025 Buyback Activity & Expert Approved Trade Ideas - Newser
Alumis Insider Bought Shares Worth $2,039,901, According to a Recent SEC Filing - marketscreener.com
Alumis Inc (ALMS) director Akkaraju buys shares worth $2m By Investing.com - Investing.com Canada
Alumis Inc (ALMS) director Akkaraju buys shares worth $2m - Investing.com
Why Alumis Inc. stock is a must watch in 2025Gold Moves & High Accuracy Trade Alerts - Newser
ALMS SEC FilingsAlumis Inc 10-K, 10-Q, 8-K Forms - Stock Titan
Alumis (NASDAQ:ALMS) Shares Gap Up on Insider Buying Activity - MarketBeat
Insider Buying: Alumis (NASDAQ:ALMS) Director Purchases 38,702 Shares of Stock - MarketBeat
Alumis (NASDAQ:ALMS) Director Buys $370,822.68 in Stock - MarketBeat
Srinivas Akkaraju Acquires 86,350 Shares of Alumis (NASDAQ:ALMS) Stock - MarketBeat
Alumis Insider Bought Shares Worth $1,310,677, According to a Recent SEC Filing - marketscreener.com
Alumis (ALMS) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Director Makes Major Investment in Alumis Inc. Stock! - TipRanks
Street Watch: Is Alumis Inc stock dividend yield sustainableMarket Rally & Stepwise Entry and Exit Trade Signals - BỘ NỘI VỤ
Why Alumis Inc. stock remains on buy listsTrade Exit Summary & Real-Time Volume Analysis - BỘ NỘI VỤ
Alumis reports Q3 revenue $2.07M, consensus $3.14M - MSN
Alumis Inc. $ALMS Shares Purchased by Foresite Capital Management VI LLC - MarketBeat
Major Stakeholders Show Confidence in Alumis Inc. with Significant Stock Purchases! - TipRanks
Insider Buying: Alumis (NASDAQ:ALMS) Director Acquires 125,743 Shares of Stock - MarketBeat
Tananbaum James B. buys Alumis Inc (ALMS) stock worth $532924 By Investing.com - Investing.com Canada
Tananbaum James B. buys Alumis Inc (ALMS) stock worth $532924 - Investing.com
[Form 4] ALUMIS INC. Insider Trading Activity - Stock Titan
Alumis Insider Bought Shares Worth $532,925, According to a Recent SEC Filing - marketscreener.com
Owner Foresite Labs LLC Buys 72,212 ($532.9K) Of Alumis Inc [ALMS] - TradingView
Foresite Capital Management VI LLC's Strategic Acquisition of Al - GuruFocus
Alumis director Akkaraju buys $905,349 in ALMS stock By Investing.com - Investing.com India
Director Makes a Bold Move with Major Stock Purchase in Alumis Inc. - TipRanks
Alumis director Akkaraju buys $905,349 in ALMS stock - Investing.com
Alumis Inc.’s ESK-001 Study: A Potential Game-Changer for Hepatic Impairment Treatment? - MSN
How Alumis Inc. stock performs in rising dollar environmentEarnings Trend Report & Precise Swing Trade Entry Alerts - newser.com
Alumis Inc. (NASDAQ:ALMS) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed By Investing.com - Investing.com Australia
Alumis Inc. Stock (ALMS) Opinions on Insider Purchases and Clinical Updates - Quiver Quantitative
Insider Trading Spotlight: Wednesday’s Top Buys and Sells Revealed - Investing.com
Finanzdaten der Alumis Inc-Aktie (ALMS)
Umsatz
Nettogewinn
Free Cashflow
ENV
Alumis Inc-Aktie (ALMS) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| AKKARAJU SRINIVAS | Director |
Dec 02 '25 |
Buy |
7.55 |
96,000 |
724,800 |
912,849 |
| AKKARAJU SRINIVAS | Director |
Dec 04 '25 |
Buy |
8.18 |
66,027 |
540,101 |
1,078,876 |
| AKKARAJU SRINIVAS | Director |
Dec 01 '25 |
Buy |
7.46 |
86,350 |
644,171 |
816,849 |
| AKKARAJU SRINIVAS | Director |
Nov 26 '25 |
Buy |
7.64 |
48,537 |
370,823 |
691,797 |
| AKKARAJU SRINIVAS | Director |
Nov 28 '25 |
Buy |
7.64 |
38,702 |
295,683 |
730,499 |
| Foresite Capital Management VI | 10% Owner |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| Tananbaum James B. | Director |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| Foresite Labs, LLC | 10% Owner |
Nov 21 '25 |
Buy |
7.38 |
72,212 |
532,925 |
2,614,215 |
| AKKARAJU SRINIVAS | Director |
Nov 20 '25 |
Buy |
7.20 |
125,743 |
905,350 |
643,260 |
| Foresite Labs, LLC | 10% Owner |
Nov 19 '25 |
Buy |
6.56 |
190,500 |
1,249,680 |
2,542,003 |
1.22%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):